Mannheimia haemolytica | |
---|---|
Scientific classification ![]() | |
Domain: | Bacteria |
Kingdom: | Pseudomonadati |
Phylum: | Pseudomonadota |
Class: | Gammaproteobacteria |
Order: | Pasteurellales |
Family: | Pasteurellaceae |
Genus: | Mannheimia |
Species: | M. haemolytica |
Binomial name | |
Mannheimia haemolytica (Newsom & Cross, 1932) Angen et al., 1999 [1] | |
Synonyms [1] | |
|
Mannheimia haemolytica is a species of Gram-negative bacteria belonging to the family Pasteurellaceae. It is a facultatively anaerobic, non-spore-forming, and non-motile coccobacillus. M. haemolytica is a primary bacterial pathogen implicated in the bovine respiratory disease complex (BRDC), also commonly known as "shipping fever," particularly affecting cattle, sheep, and goats.
Mannheimia haemolytica was originally described as Pasteurella haemolytica by Newsom and Cross in 1932, based on bipolar organisms isolated from cases of pneumonia in sheep and cattle. [2] For decades, it was classified within the genus Pasteurella. However, advances in molecular taxonomy led to a reassessment of the [Pasteurella] haemolytica complex. In 1999, Angen and colleagues conducted a comprehensive study using DNA–DNA hybridization and 16S rRNA gene sequencing, which demonstrated sufficient genetic divergence to warrant creation of a new genus, Mannheimia. [3]
Mannheimia haemolytica primarily colonizes the upper respiratory tract of cattle and other ruminants but can become pathogenic under stress conditions such as transport, crowding, or viral infections. This bacterium secretes leukotoxins, endotoxins, and other virulence factors that damage respiratory tissues and impair host immunity, resulting in severe fibrinous pneumonia. [4]
Affected cattle commonly exhibit symptoms such as fever, depression, reduced appetite, nasal discharge, coughing, and difficulty breathing. In severe cases, animals can rapidly progress to acute respiratory distress and death if untreated. [4]
Diagnosis of Mannheimia haemolytica infection typically involves bacterial culture from nasal swabs, lung tissue, or bronchoalveolar lavage samples. Samples are commonly cultured on blood agar, where M. haemolytica forms characteristic β-hemolytic colonies. Confirmation is supported by biochemical tests and species-specific polymerase chain reaction (PCR) assays. In research and advanced diagnostic contexts, whole genome sequencing (WGS) is increasingly used to characterize isolates, monitor strain diversity, and investigate antimicrobial resistance. [5]
Effective management of Mannheimia haemolytica infections involves prompt administration of appropriate antibiotics, such as macrolides (e.g., tulathromycin, gamithromycin), tetracyclines, or fluoroquinolones. However, the emergence of antimicrobial resistance, including multidrug-resistant strains, underscores the importance of prudent antibiotic use and the need for alternative control strategies. [6]
Preventative measures include vaccination programs targeting prevalent serotypes. Studies have shown that vaccines incorporating multiple serotypes, such as A1 and A6, or recombinant proteins like leukotoxin, can enhance protective efficacy. [7] In addition, good husbandry practices such as reducing stress, ensuring adequate ventilation, and avoiding overcrowding can reduce the risk of disease. [8]